EYENOVIA INC (EYEN)
US30234E1047 - Common Stock
EYENOVIA INC
NASDAQ:EYEN (11/15/2024, 8:06:08 PM)
After market: 0.103 +0 (+1.08%)0.1019
-0.24 (-70.04%)
Company Profile
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 57 full-time employees. The company went IPO on 2018-01-25. The company is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Company Info
EYENOVIA INC
295 Madison Ave Ste 2400
New York City NEW YORK 10017
P: 18137669539
CEO: Tsontcho Ianchulev
Employees: 57
Website: https://eyenovia.com/
EYEN News
a day ago - ChartmillKeep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.Which stocks are experiencing notable movement on Friday?
a day ago - ChartmillHere are the top movers in Friday's session, showcasing the stocks with significant price changes.Top movers analysis in the middle of the day on 2024-11-15: top gainers and losers in today's session.
a day ago - ChartmillThere are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.Let's have a look at the gap up and gap down stocks in today's session.
a day ago - ChartmillTop movers in Friday's pre-market sessionAs we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
a day ago - Eyenovia, Inc.Eyenovia Provides Update on Phase 3 CHAPERONE StudyA review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy endpoint Company to...
4 days ago - Eyenovia, Inc.Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateAdvanced Phase 3 CHAPERONE study of MicroPine as a treatment of pediatric progressive myopia with preparations for interim analysis this quarter Commenced...
EYEN Twits
Here you can normally see the latest stock twits on EYEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
